Fact CheckerSign in

NCT05922293Completed

Combined Effects of Blow Bottle Technique and Percussion Technique in COPD Patients

Combined Effects of Blow Bottle Technique and Percussion Technique in Patients With Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 27 Dec 2023

Brief summary (registry, in English)

It will be a randomized control trial. Participants will be recruited according to inclusion criteria and will be allocated into 2 groups using convenience sampling technique. Group 1 will be treated with percussion technique for 30 min and group 2 with blow bottle technique combined with percussion technique for 30 min at DHQ Teaching Hospital Gujranwala. Intervention will be carried out for total 4 weeks of duration with 3 sessions per week. Outcome measures such as dyspnea, breathlessness, sputum and cough, O2 and pulse rate, expiratory flow rate will be measured by tools as mMRC, BCSS, peak flow meter respectively. Assessment will be done before and after intervention and result will be analyzed using statistical package for social sciences SPSS 20.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
6 Jun 2023
Start date
15 Jun 2023
Primary completion date
15 Sept 2023
Lead sponsor
Riphah International University
Diseases
COPD
NCT number
NCT05922293

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 15 Jun 2023 to the primary completion date, 15 Sept 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • cardiovascular impairment,
  • neurological disease

Other

  • Clinically unstable
  • musculoskeletal dysfunction

Who the study is looking for

  • Mild-to-Moderate COPD (according to GOLD criteria)
  • Both gender (male and female)
  • Aged between 35 and 80 years

Age in the registry: 35 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
DHQ Teaching Hospital
Coordinator of this site? Confirm its status
GujranwalaPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.